Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 8, 2017, during market hours
10-Q filed Aug 8, 2017, 39 days after period end · 0001171843-17-004806
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | $2.50K | $5.00K |
| Net Income | -$4.65M | -$3.85M | -$5.45M | -$6.75M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.47 |
| -$0.06 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
